CLINICAL_TRIALS
trial_result
· 2009-07-20
Clinical Trial Update: PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin [Phase 3]
Summary
Phase 3 PLUTO trial evaluated rosuvastatin for lipid reduction in children with familial hypercholesterolemia; the results were posted in July 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2009-07-20